Aurinia Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.About AUPH
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
AUPH Key Statistics
Stock Snapshot
With a market cap of 2.12B, Aurinia Pharmaceuticals(AUPH) trades at $15.96. The stock has a price-to-earnings ratio of 7.62.
As of 2026-05-05, Aurinia Pharmaceuticals(AUPH) stock has fluctuated between $15.67 and $16.02. The current price stands at $15.96, placing the stock +1.9% above today's low and -0.4% off the high.
Aurinia Pharmaceuticals(AUPH) shares are trading with a volume of 258.71K, against a daily average of 1.12M.
During the past year, Aurinia Pharmaceuticals(AUPH) stock moved between $7.29 at its lowest and $16.88 at its peak.
During the past year, Aurinia Pharmaceuticals(AUPH) stock moved between $7.29 at its lowest and $16.88 at its peak.
Analyst ratings
50%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.